| Literature DB >> 28347271 |
Marie-Hélène Nicolas-Chanoine1,2,3, Marie Petitjean4,5, Azucena Mora6, Noémie Mayer7, Jean-Philippe Lavigne8,9, Olivier Boulet10, Véronique Leflon-Guibout7, Jorge Blanco6, Didier Hocquet4,5.
Abstract
BACKGROUND: In 2006, we found healthy subjects carrying ST131 Escherichia coli in their intestinal microbiota consisting of two populations: a subdominant population of fluoroquinolone-resistant E. coli belonging to subclone H30 (H30-R or subclade C1), the current worldwide dominant ST131 subclone, and a dominant E. coli population composed of antibiotic-susceptible E. coli belonging to subclone H22 (clade B), the precursor of subclone H30. We sequenced the whole genome of fecal H22 strain S250, compared it to the genomes of ExPEC ST131 H30-Rx strain JJ1886 and commensal ST131 H41 strain SE15, sought the H22-H30 genomic differences in our fecal strains and assessed their phenotypic consequences.Entities:
Keywords: Biofilm; E. coli ST131; H22 genome; Mannose-binding FimH region; Plasmid replicons; Subclades B; Sugar metabolism
Mesh:
Substances:
Year: 2017 PMID: 28347271 PMCID: PMC5369007 DOI: 10.1186/s12866-017-0984-8
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Characterization of the seven fecal strains of E. coli ST131
| Strain/ | Susceptibility | β-lactamase | Allele typea(amino acid substitution) | Flag-2 | Phi3 | GI-PheV | Subclade | IncF plasmid replicon | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMX | AMC | CIP | GEN | AMK | SXT | FOS |
|
|
| |||||||
| S250/ | S | S | S | S | S | S | S | − | 1a | 1 | NA (I529L) | − | − | − | B1 | F89:A-:B62 |
| 208/ | S | S | S | S | S | S | S | − | 1a | 1 | NA (I529L) | + | − | − | B2 | − |
| 196/ | R | S | S | S | S | R | S | TEM-1 | 1a | 1 | NA (I529L) | + | − | + | B4 | F24:A-:B6 |
| 187/ | R | S | R | S | S | S | S | TEM-1 | 1AB (S83 L/D87N) | 1aAB (S80I/E84V) | NA (I529L) | + | + | + | C1 | F1:A2:B20 |
| 183/ | R | S | R | S | S | S | S | TEM-1 | 1AB (S83 L/D87N) | 1aAB (S80I/E84V) | NA (I529L) | + | + | + | C1 | F1:A2:B20 |
| 39/ | R | S | R | S | S | S | S | TEM-1 | 1AB (S83 L/D87N) | 1aAB (S80I/E84V) | NA (I529L) | + | + | + | C1 | F1:A2:B20 |
| 02/ | R | S | R | S | S | S | S | TEM-1 | 1AB (S83 L/D87N) | 1aAB (S80I/E84V) | NA (I529L) | + | + | + | C1 | F1:A2:B20 |
aaccording to reference [3], AMX amoxicillin, AMC amoxicillin + clavulanic acid, CIP ciprofloxacin, GEN gentamicin, AMK amikacin, SXT cotrimoxazole, FOS fosfomycin, R resistant, S susceptible, −: absence, +: presence, NA not available
Fig. 1List of genes found in the genomes of H22 strain S250, H30-Rx strain JJ1186 and, H41 strain SE15. Each strain is represented by a circle and each gene commonly found in the genome of two strains or in the genome of the three strains is indicated in the corresponding intersecting regions, whereas genes specific for each strain are indicated in the section of the circle not shared with another circle. The 148 genes present in the three strains are listed at the bottom of the figure
Virulence factor-encoding genes, virotype, and ExPEC status of human fecal ST131 Escherichia coli H22 and H30 subclones
| Strain |
| Virulence factor-encoding gene | Virotype | ExPEC status |
|---|---|---|---|---|
| S250 |
|
| D | - |
| 208 |
|
| D | - |
| 196 |
|
| D | - |
| 187 |
|
| C | - |
| 183 |
|
| C | - |
| 39 |
|
| C | + |
| 02 |
|
| C | - |
Fig. 2Alignment of FimH sequence from various Escherichia coli strains. Phylogroup B2 E. coli: ST73 strain CFT073, H30 ST131 JJ1886, H30 ST131 uk_P46212, H22 ST131 S250 and H41 ST131 SE15; phylogroup A: MG1655. “1” indicates the start of the FimH protein. Amino acid positions involved in binding to mono-mannose and tri-mannose structures are indicated in grey
Distribution of the genes involved in sugar metabolism in commensal Escherichia coli strains HS and Nissle [29] in the genomes of representative H30, H22, and H41 subclones of Escherichia coli ST131
| Commensal strain/gene | Catabolized sugar |
|
|
|
|---|---|---|---|---|
|
| ||||
|
| Arabinose | + | + | + |
|
| Arabinose | + | + | + |
|
| Arabinose | + | + | + |
|
| Fucose | + | + | + |
|
| Galactose | + | + | + |
|
| Gluconate | + | + | + |
|
| Gluconate | − | − | + |
|
| Lactose | + | + | + |
|
| Mannose | + | + | + |
|
| N-acetylglucosamine | + | + | + |
|
| N-acetylneuraminate | + | + | + |
|
| N-acetylneuraminate | + | + | + |
|
| Ribose | + | + | + |
|
| Glucuronate | + | + | + |
|
| ||||
|
| N-acetylgalactosamine | + | + | + |
|
| N-acetylgalactosamine | + | + | + |
|
| N-acetylgalactosamine | + | + | + |
|
| N-acetylgalactosamine | + | + | + |
Fig. 3Growth of human fecal subclone H30 and subclone H22 strains of ST131 Escherichia coli in minimal medium plus 0.2% gluconate. Strain growth was assessed by measuring the OD at 600 nm after 48 h of incubation. Bars represent the standard deviation obtained from three independent experiments
Fig. 4Early biofilm formation by human fecal subclone H30 and subclone H22 strains of ST131 Escherichia coli. BioFilm Control® image analysis software was used and results are expressed as the proportion of immobilized beads relative to reference conditions (% RBI) according to incubation time. Bars represent the standard deviation obtained from three independent experiments performed in duplicate. The biofilm is more fully formed (beads are immobilized) as RBI approaches a value of 1. Significant differences between H22 and H30 using Dunnett’s test are indicated by * (p < 0.05), ** (p < 0.01) and *** (p < 0.001)
Distribution of the 10 methyltransferases previously described in H30 strain EC958, [31] in the genomes of representative H30, H22, and H41 subclones of Escherichia coli ST131
| Methyltransferase ( |
|
|
|
|---|---|---|---|
| M.EcoMIV | + | − | − |
| M.EcoMV | + | − | − |
| M.EcoMDcm | + | + | + |
| EcoMIII | + | − | + |
| M.EcoMVI | + | + | + |
| M.EcoMDam | + | + | + |
| M.EcoMVII | − | − | − |
| M1.EcoMI | + | − | + |
| M2.EcoMI | + | − | + |
| M.EcoMII | + | − | − |
| Total number | 9 | 3 | 6 |
+: presence,-: absence